Your browser doesn't support javascript.
loading
Tissue resident memory T cells are enriched and dysfunctional in effusion of patients with malignant tumor.
Mao, Xueying; Chen, Yue; Lu, Xiulian; Jin, Shuiping; Jiang, Piao; Deng, Zhangfeng; Zhu, Xiaoyun; Cai, Qichun; Wu, Changyou; Kang, Shuangpeng.
Afiliação
  • Mao X; Clinical Research Center of Clifford Hospital, Guangzhou, P.R. China.
  • Chen Y; Cancer Center of Clifford Hospital, Guangzhou, P.R. China.
  • Lu X; Obstetrics of Clifford Hospital, Guangzhou, P.R.China.
  • Jin S; Clinical Research Center of Clifford Hospital, Guangzhou, P.R. China.
  • Jiang P; Clinical Research Center of Clifford Hospital, Guangzhou, P.R. China.
  • Deng Z; Clinical Research Center of Clifford Hospital, Guangzhou, P.R. China.
  • Zhu X; Clinical Research Center of Clifford Hospital, Guangzhou, P.R. China.
  • Cai Q; Cancer Center of Clifford Hospital, Guangzhou, P.R. China.
  • Wu C; Clinical Research Center of Clifford Hospital, Guangzhou, P.R. China.
  • Kang S; Academician Workstation, Hunan Key Laboratory of the Research and Development of Novel Pharmaceutical Preparations, Changsha Medical University, Changsha, P.R. China.
J Cancer ; 14(7): 1223-1231, 2023.
Article em En | MEDLINE | ID: mdl-37215450
ABSTRACT
Purpose Most malignant effusion is secondary to metastases to the pleura or peritoneum and portend poor oncological outcomes. Malignant effusion has different tumor microenvironment from primary tumor, containing a variety of cytokines and immune cells and directly contacting with tumor cells. However, the characteristic of CD4+ T cells and CD8+ T cells in malignant effusion remains unclear. Methods Malignant effusion including peritoneal ascites and pleural fluid from thirty-five patients with malignant tumor were collected and compared with matched blood. A detailed characterization of CD4+ T cells and CD8+ T cells in malignant effusion were conducted using flow cytometry and multiple cytokines assay. Results The concentration of IL-6 in malignant effusion was significantly higher than in blood. A substantial portion of T cells in malignant effusion were CD69+ and/ or CD103+ Trm cells. Most CD4+T and CD8+T cells in malignant effusion were exhausted T cells which expressed lower levels of cytokines, cytotoxic molecules and markedly higher levels of inhibitory receptor PD-1 compared with in blood. Conclusion Our study is the first to identify the presence of Trm cells in malignant effusion and will lay the foundation for future research on anti-tumor immunity of Trm cells in malignant effusion.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article